Back to Anacor Homepage Developing Drug Candidates Through Boron Chemistry
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
Investors overview.gif
Investor Relations Contact:
Phone: 650-543-7575

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Anacor Pharmaceuticals, Inc.'s financial performance into perspective.

View all »Recent Releases

Jun 29, 2015
Anacor Pharmaceuticals Announces Amendment to KERYDIN Commercialization Agreement

Jun 1, 2015
Anacor Pharmaceuticals Names Graeme Bell as New Executive Vice President and Chief Financial Officer

View all »Events & Presentations

Jun 10, 2015 at 3:20 PM PT
Goldman Sachs 36th Annual Global Healthcare Conference

Jun 2, 2015 at 4:00 PM ET
Jefferies Healthcare Conference

May 13, 2015 at 5:00 PM PT
Bank of America Merrill Lynch 2015 Healthcare Conference

Receive Email Alerts

Sign up to receive e-mail alerts whenever Anacor posts new information to the site.

Price: 76.05 Change: -0.42
High: 77.34 %Change: 0.549%
Low: 75.00 Volume: 656,100